title: Update on imaging of vulvar squamous cell carcinoma.
abstract: OBJECTIVE
  The purpose of this article is to describe the advantages and diagnostic and prognostic implications of imaging in the management of vulvar carcinoma.
  
  
  CONCLUSIONS
  As the treatment of vulvar carcinoma evolves to tailored surgery and chemoradiation therapy to reduce morbidity, the importance of pretreatment assessment of vulvar carcinoma increases. Advances in imaging, such as pelvic MRI and PET, add to the benefits of clinical evaluation in pretreatment planning, assessment of response to chemoradiation therapy, and posttreatment surveillance.
authors.affiliation: Department of Radiology, Dana-Farber Cancer Institute, Boston, MA, USA. medimash@gmail.com
authors.forename: Kyung Won
authors.initials: KW
authors.lastname: Kim
authors.forename: Atul B
authors.initials: AB
authors.lastname: Shinagare
authors.forename: Katherine M
authors.initials: KM
authors.lastname: Krajewski
authors.forename: Stephanie A
authors.initials: SA
authors.lastname: Howard
authors.forename: Jyothi P
authors.initials: JP
authors.lastname: Jagannathan
authors.forename: Katherine
authors.initials: K
authors.lastname: Zukotynski
authors.forename: Nikhil H
authors.initials: NH
authors.lastname: Ramaiya
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D003952:Diagnostic Imaging; D005260:Female; D006801:Humans; D014846:Vulvar Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy